SCHEMBL16174997

SCHEMBL16174997

CCC(=O)OC(=O)c1ccc(C)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.57
ALDH1A1 P00352 8/20 0.48
LMNA P02545 3/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
KMT2A Q03164 4/20 0.47
GAA P10253 2/20 0.47
MAPT P10636 4/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
ESR1 P03372 2/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
ESR2 Q92731 1/20 0.47
CA14 Q9ULX7 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098839 0.88 TDP1 (0.57) TDP1ALDH1A1LMNACES2CES1
SCHEMBL8995839 0.86 TDP1 (0.52) TDP1ALDH1A1LMNACES2CES1
SCHEMBL31176004 0.86 TDP1 (0.55) TDP1ALDH1A1LMNACES2CES1
SCHEMBL6654554 0.84 TDP1 (0.70) TDP1ALDH1A1LMNACES2CES1
SCHEMBL248492 0.84 TDP1 (0.70) TDP1ALDH1A1LMNACES2CES1
SCHEMBL28646948 0.84 TDP1 (0.53) TDP1ALDH1A1LMNACES2CES1
SCHEMBL8371274 0.84 TDP1 (0.53) TDP1ALDH1A1LMNACES2CES1
SCHEMBL775876 0.84 TDP1 (0.53) TDP1ALDH1A1LMNACES2CES1
SCHEMBL6655202 0.83 ESR1 (0.62) TDP1ALDH1A1LMNAKMT2AMAPT
SCHEMBL27818338 0.82 L3MBTL1 (0.47) TDP1ALDH1A1LMNAKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108430989-B Process for preparing 1, 4-dihydropyridine-3, 5-dicarboxylate derivatives and intermediates 轩竹生物科技有限公司 2021-10-08 CN disclosed
US-9150723-B2 Curable resin composition THREE BOND FINE CHEMICAL CO., LTD. (JP) 2015-10-06 US disclosed
US-20150239864-A1 3H-1,2-DITHIOCYCLOPENTENE-3-THIOKETONE COMPOUNDS AND APPLICATION THEREOF SOOCHOW UNIVERSITY (CN) 2015-08-27 US disclosed
EP-2889294-A1 3H-1,2-DITHIOCYCLOPENTENE-3-THIOKETONE COMPOUNDS AND APPLICATION THEREOF Soochow University (CN) 2015-07-01 EP disclosed
US-20140329926-A1 CURABLE RESIN COMPOSITION THREE BOND FINE CHEMICAL CO., LTD (JP) 2014-11-06 US disclosed
EP-2792694-A1 CURABLE RESIN COMPOSITION Three Bond Fine Chemical Co., Ltd. (JP) 2014-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239864-A1 3H-1,2-DITHIOCYCLOPENTENE-3-THIOKETONE COMPOUNDS AND APPLICATION THEREOF TXN2, TXN, TXNRD2 TDP1 445/4885ALDH1A1 370/4885LMNA 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.